Motus GI Holdings Inc (MOTS OTCQB) stock market data APIs
$0.0001
0(0%)
as of September 12, 2025
Try our APIs with
free plan!
Motus GI Holdings Inc Financial Data Overview
Price chart is built with
Anychart
Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.
Prev. Close
0.0001
Open
0.0001
High
0.0001
Low
0.0001
52 wk Range
0.0001-0.05
Market Cap
639
Shares Outstanding
6 389 K
Revenue
327 K
EPS
-0.2453
Beta
0.996
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Motus GI Holdings Inc data using free add-ons & libraries
Get Motus GI Holdings Inc Fundamental Data
Motus GI Holdings Inc Fundamental data includes:
- Net Revenue: 327 K
- EBITDA: -9 145 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2024-05-14
- EPS/Forecast: -5.48
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Motus GI Holdings Inc News
New
Motus GI Reports Third Quarter 2023 Financial Results and Provides Corporate Update
First case performed using the new FDA cleared Pure-Vu® EVS Gastro system, and expect to initiate broader market introductions by the end of 2023 Pure-Vu EVS Gastro addresses the Upper GI market, an ...
Motus GI Announces First Upper GI Patient Procedure for FDA Cleared Pure-Vu® EVS Gastro
- - - The upper GI procedure was performed by Dr. Brian Hanson, gastroenterologist and Assistant Professor, Medicine, at the University of Minnesota - - - Pure-Vu EVS Gastro addresses the Upper GI mar...
Motus GI Announces 1-for-15 Reverse Stock Split
FORT LAUDERDALE, Fla., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company focused on improving endoscopic ou...
Motus GI Receives FDA Clearance to Commercialize Pure-Vu EVS Gastro and Gen 4 Colon
– Clearance opens up the potential breakthrough opportunity in the Upper GI market, an area of high unmet clinical need – – Technological advancements featured in new generation of the Pure-Vu ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
